Neoadjuvant Chemotherapy Before Bladder‐Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle‐Invasive Bladder Cancer
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.09.021
Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta‐Analysis of Available Clinical Trials
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.12.011
More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.003
Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.007
Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.008
The Effect of Treatment Sequence on Overall Survival for Men With Metastatic Castration-resistant Prostate Cancer: A Multicenter Retrospective Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.09.006
Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.011
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.04.013
Exploratory Investigation of Target Pazopanib Concentration Range for Patients With Renal Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.12.001
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear‐Cell and Papillary Renal‐Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.10.008
Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.09.006
Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.010
Stereotactic Radiosurgery for Multiple Brain Metastases From Renal‐Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.006
Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.08.007
COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.01.015
Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.02.002
Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.11.017
Pathologic Nodal Involvement in Patients With Penile Cancer With Cavernosal Versus Spongiosal Involvement
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.10.004
Drug-Drug Interactions in Prostate Cancer Treatment.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.016
Moreau Strain Bacillus Calmette-Guérin Low Versus Standard Dose in the Treatment of High-Grade T1 Bladder Cancer: A Retrospective Observational Cohort Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.04.003
Renal Neuroendocrine Neoplasms: A Single-center Experience.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.11.003
Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.03.006
Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2018.11.015
METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.12.010
Real World Experience With Pembrolizumab in Recurrent or Advanced Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.12.009
Denosumab Toxicity When Combined With Anti‐angiogenic Therapies on Patients With Metastatic Renal Cell Carcinoma: A GETUG Study
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.08.006
Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.04.008
Radical Prostatectomy Sociodemographic Disparities Based on Hospital and Physician Volume.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.027
Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.06.002
Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.006
Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.05.017
Assessing Outcomes and Prognostic Factors for First-Line Therapy in Elderly Patients With Metastatic Renal Cell Carcinoma: Real-Life Data From a Single United Kingdom Institution.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.03.012
Single Subcutaneous Prostate Cancer Metastasis Detected by 68Ga‐PSMA PET/CT During Early Biochemical Relapse: A Case Report
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.012
Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.012
Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.023
A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.07.008
Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.001
Development of a Novel Prognostic Risk Score for Predicting Complications of Penectomy in the Surgical Management of Penile Cancer
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.09.018
Favorable Response to Pembrolizumab in a Patient With Metastatic Castration‐Resistant Prostate Cancer Progressing While Receiving Enzalutamide
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.021
Implications of Cystectomy Travel Distance for Hospital Readmission and Survival.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.08.005
Cost‐Effectiveness of Second‐Line Treatments for Metastatic Renal‐Cell Carcinoma
来源期刊：Clinical Genitourinary CancerDOI：10.1016/j.clgc.2018.11.010
Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.11.006
Targeted and Systematic Prostate Biopsy in Biopsy-naive Men With Positive Multiparameter Magnetic Resonance Imaging Findings: A Meta-analysis.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.10.004
Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.016
High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.06.004
Single Versus Maintenance Intravesical Chemotherapy for the Prevention of Bladder Recurrence after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Randomized Clinical Trial.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.07.019
Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel.
来源期刊：Clinical genitourinary cancerDOI：10.1016/j.clgc.2019.10.002
Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.06.006
Association of Hyponatremia With Survival in Patients With Castration-resistant Prostate Cancer: A Clinical Commentary.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.08.001
Application of Everolimus in Preoperative Neoadjuvant Therapy of Tuberous Sclerosis Complex Associated With Renal Angiomyolipoma: A Single-Center Report of 5 Cases.
来源期刊：Clinical genitourinary cancerDOI：10.1016/J.CLGC.2019.07.005
投稿咨询
加急服务
论文发表
2-4个月录用
7500+文章录用
不成功可退款
